| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |